Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Direcional launches new share buyback program for up to 32 million shares

Direcional launches new share buyback program for up to 32 million shares

ReutersReuters2026/08/11 21:15
  • Direcional Engenharia mengesahkan hasil rapat dewan 11 Agustus 2026, termasuk program buyback saham baru menggantikan program berjalan.
  • Program buyback membatasi posisi bersih saham treasuri pada 32.000.000 saham; periode pelaksanaan 12 Agustus 2026–12 Februari 2028.
  • Dewan juga mengesahkan laporan keuangan kuartal II 2026 beserta laporan auditor independen.
  • Komite Pengungkapan Informasi Material dipilih kembali: Paulo Henrique Martins de Sousa sebagai ketua, Ricardo Valadares Gontijo, Ricardo Ribeiro Valadares Gontijo.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Direcional Engenharia SA published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.